News
Bevacizumab, Aflibercept Compared for Neovascular AMD
At the end of one year, likelihood of being weaned off treatment was higher for eyes treated with aflibercept versus bevacizumab
At the end of one year, likelihood of being weaned off treatment was higher for eyes treated with aflibercept versus bevacizumab